Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements{star, open}

Research in Social and Administrative Pharmacy

Volumn 1, Issue 2, 2005, Pages 231-250

  Schommer, Jon C ^a   Singh, Reshmi L ^a   Hansen, Richard A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERTIZING; ARTICLE; ATTITUDE TO HEALTH; DEMOGRAPHY; DOCTOR PATIENT RELATION; FEMALE; HEALTH BEHAVIOR; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; PATIENT; PRESCRIPTION;

ADVERTISING; ADVERTISING AS TOPIC; DATA COLLECTION; DEMOGRAPHY; DRUG PRESCRIPTIONS; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENTS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTIONS, DRUG;

EID: 33745962043     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2005.03.009     Document Type: Article

References (67)

1. Food and Drug Administration. Guidance for Industry: Consumer-directed Broadcast Advertisements (Draft Guidance) (1997), Division of Drug Marketing, Advertising, and Communications (DDMAC), Rockville, Md 62 Federal Register at 43,171 July 1997
2. Food and Drug Administration. Guidance for Industry: Consumer-directed Broadcast Advertisements (1999), Division of Drug Marketing, Advertising, and Communications (DDMAC), Rockville, Md. http:www.fda.gov/cder/guidance/index.htm
3. Schommer Jon C, Doucette William R. Consumer Preferences for and Retention of Information from Direct-to-Consumer Advertising. Presented at National Council on Patient Information and Education 12th National Conference, Washington, DC. May 13, 1999.
4. Slaughter E. An Assessment of Consumer Reaction to Direct-to-consumer Advertising. Presented at American Pharmaceutical Association 146th Annual Meeting, San Antonio, Tex, March 9, 1999.
5. Baylor-Henry. Regulation of prescription drug promotion: direct-to-consumer advertising. Clinical Therapeutics 20 (1998) C86-C95
6. Wilkes M.S., Bell R.A., and Kravitz R.L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs 19 (2000) 110-128
7. Levy S. DTC ads prompting mature consumers to visit the doctor. Drug Topics 143 (1999) 21
8. Aikin K. Direct-to-consumer Advertising of Prescription Drugs: Preliminary Patient Survey Results (2002), FDA, Division of Drug Marketing, Advertising and Communications, Rockville, Md
9. FDA, Office of Medical Policy, Division of Drug Marketing, Advertising and Communications. Attitudes and Behaviors Associated with Direct-to-consumer (DTC) Promotion of Prescription Drugs: Main Survey Results (1999), FDA, Rockville, Md
10. Slaughter Ed. 5th Annual Survey: Consumer Reaction to DTC Advertising of Prescription Medicines, 2001-2002 (2002), Rodale, Inc, Emmaus, Pa
11. Slaughter Ed., and Schumacher M. Prevention's International Survey on Wellness and Consumer Reaction to DTC Advertising of Rx Drugs, 2000-2001 (2001), Rodale, Inc, Emmaus, Pa
12. Prevention Magazine. Year Two: A National Survey of Consumer Reactions to Direct-to-consumer Advertising, 1999 (1999), Rodale, Inc, Emmaus, Pa
13. Prevention Magazine. National Survey of Consumer Reactions to Direct-to-consumer Advertising, 1998 (1998), Rodale, Inc, Emmaus, Pa
14. Prevention Magazine. Navigating the Medication Marketplace: How Consumers Choose, 1997 (1997), Rodale, Inc, Emmaus, Pa
15. Henry J., and Kaiser Family Foundation. Understanding the Effects of Direct-to-consumer Prescription Drug Advertising (2001), Henry J. Kaiser Family Foundation, Menlo Park, Calif
16. National Consumers League. Health Care Information and the Consumer: A Public Opinion Survey (1998), National Consumers League, Washington, DC
17. Foley L., and Gross D. Are Consumers Well Informed About Prescription Drugs? The Impact of Printed Direct-to-consumer Advertising (2000), AARP, Washington, DC
18. Weissman J.S., Blumenthal D., Silk A.J., Zapert K., Newman M., and Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Affairs (2003) W3-82-W3-95 web exclusive
19. White H.J., Draves L.P., Soong R., and Moore C. Ask your doctor! Measuring the effect of direct-to-consumer communications in the world's largest healthcare market. International Journal of Advertising 23 (2004) 53-68
20. Aikin Kathryn, Swasy John L, Braman Amie C. Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Prescription Drugs - Summary of FDA Survey Research Results, Final Report, November 19, 2004. Rockville, Md: Food and Drug Administration, Center for Drug Evaluation and Research.
21. Chelimsky Eleanor. Prescription Drugs, Little is Known About the Effects of Direct-to-Consumer Advertising. General Accounting Office, Program Evaluation and Methodology Division, 91-19: Washington, DC; 1991.
22. Chelimsky Eleanor. Prescription Drugs, Selected Direct-to-Consumer Advertising Studies Have Methodological Flaws. General Accounting Office, Program Evaluation and Methodology Division, 91-20: Washington, DC; 1991.
23. Doucette W.R., and Schommer J.C. Consumer preferences for drug information after direct-to-consumer advertising. Drug Information Journal 32 (1998) 1081-1088
24. Glasgow C., Schommer J.C., Gupta K., and Pierson K. Promotion of prescription drugs to consumers: case study results. Journal of Managed Care Pharmacy 8 (2002) 512-518
25. Hollon M. Direct-to-consumer marketing of prescription drugs: creating consumer demand. Journal of the American Medical Association 281 (1999) 382
26. Holmer A. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. Journal of the American Medical Association 281 (1999) 380
27. Lyles A. Direct marketing of pharmaceuticals to consumers. Annual Reviews in Public Health 23 (2002) 73-91
28. Reeves K.N. Direct-to-consumer broadcast advertising: empowering the consumer or manipulating a vulnerable population?. Food and Drug Law Journal 53 (1998) 661-679
29. Taylor Christine and Schommer Jon C. Consumer Opinions of Direct-to-consumer Prescription Drug Advertising. Presented to the Academy of Pharmacy Practice and Management, 145th Annual Meeting of the American Pharmaceutical Association, Miami Beach, Fla, March 22, 1998.
30. Wosinksa M. Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products, Working Paper No. 03-058 (2003), Harvard Business School, Boston, Mass
31. Schommer J.C., Doucette W.R., and Mehta B.H. Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drug. Clinical Therapeutics 20 (1998) 617-632
32. Schommer Jon C., Doucette William R, Mehta Bella H. Manufacturer sponsored Web sites as an information source for consumers after viewing direct-to-consumer advertising for prescription drugs. Ecommerce Research Forum. 1999;1, http://www.ecommerce.mit.edu
33. Schommer J.C., Doucette W.R., and Worley M.M. Processing prescription drug information under different conditions of presentation. Patient Education and Counseling 43 (2001) 49-59
34. Sullivan D.L., Schommer J.C., and Birdwell S.W. Consumer retention of risk information from direct-to-consumer advertising. Drug Information Journal 33 (1999) 281-290
35. Fishbein M., Jaccard J.J., Davidson A.R., Ajzen I., and Barbara L. Predicting and understanding family planning behaviors: beliefs, attitudes, and intentions. In: Ajzen I., and Fishbein M. (Eds). Understanding Attitudes and Predicting Social Behavior (1980), Prentice-Hall, Englewood Cliffs, NJ
36. Food and Drug Administration. Attitudes and Behaviors Associated with Direct-to-Consumer Promotion of Prescription Drugs (2000), Office of Medical Policy, Division of Drug Marketing, Advertising, and Communications, Rockville, Md. www.fda.gov
37. Bentley John P, Smith Mickey C, Murawski Matthew M, Banahan Benjamin F, Wilkin Noel E, Frate Dennis A, Vitell Scott J. The Inherent Burden Associated with the Consumption of Medications, presented at the 13th Annual Meeting of the American Association of Pharmaceutical Scientists, New Orleans, La, November 17, 1999.
38. Murawski M.M., and Bentley J.P. Pharmaceutical therapy-related quality of life: conceptual development. Journal of Social and Administrative Pharmacy 18 (2000) 2-14
39. Strecher V.J., Champion V.L., and Rosenstock I.M. The health belief model and health behavior. In: Gochman D.S. (Ed). Handbook of Health Behavior Research I: Personal and Social Determinants (1997), Plenum Press, New York 71-91
40. Haugtvedt C.P. Beyond fact or artifact: an assessment of Fishbein and Middlestadt's perspectives on attitude change processes. Journal of Consumer Psychology 6 (1997) 99-106
41. Haugtvedt C.P., Petty R.E., and Cacioppo J.T. Need for cognition and advertising: understanding the role of personality variables in consumer behavior. Journal of Consumer Psychology 1 (1992) 239-260
42. Haugtvedt C.P., and Priester J.R. Conceptual and methodological issues in advertising effectiveness: an attitude strength perspective. In: Wells W. (Ed). Measuring Advertising Effectiveness (1997), Erlbaum
43. Haugtvedt C.P., Schumann D.W., Schneier W.L., and Warren W.L. Advertising repetition and variation strategies: implications for understanding attitude strength. Journal of Consumer Research 21 (1994) 176-189
44. Haugtvedt C.P., and Wegener D.T. Message order effects in persuasion: an attitude strength perspective. Journal of Consumer Research 21 (1994) 205-218
45. Mott D.A., and Schommer J.C. Prescription Drug Insurance for the Elderly: A National Survey. Presented at the 16th Annual Meeting of the Association for Health Services Research (June 28, 1999), Ill, Chicago
46. Mott D.A., and Kreling D.H. The association of insurance type with costs of prescribed drugs. Inquiry 35 (1998) 23-35
47. Mott D.A., Schommer J.C., Doucette W.R., and Kreling D.H. Agency theory and decisions within the pharmaceutical utilization system: implications for public policy. Journal of Public Policy and Marketing 17 (1998) 1-8
48. Obermiller C., and Spangenberg E.R. Development of a scale to measure consumer skepticism toward advertising. Journal of Consumer Psychology 7 (1998) 159-186
49. Kohli A., and Zaltman G. Determinants of influence in organizational buying: a contingency approach. Journal of Marketing 53 (1989) 50-65
50. Worley-Louis M., Schommer J.C., and Finnegan J.R. Construct identification and measure development for investigating pharmacist-patient relationships. Patient Education and Counseling 51 (2003) 229-238
51. Dawson S., Bloch P.H., and Ridgway N.M. Shopping motives, emotional states, and retail outcomes. Journal of Retailing 66 (1990) 408-427
52. Maheswaran D., and Sternthal B. The effects of knowledge, motivation, and type of message on ad processing and product judgments. Journal of Consumer Research 17 (1990) 66-73
53. Cole C.A., and Balasubramanian S.K. Age differences in consumers' search for information: public policy implications. Journal of Consumer Research 20 (1993) 157-169
54. Cole C.A., and Gaeth G.J. Cognitive and age-related differences in the ability to use nutritional information in a complex environment. Journal of Marketing Research 27 (1990) 174-184
55. Doucette W.R., and Wiederholt J.B. Relationships among consumer characteristics and drug therapy process variables to consumers' meaning of prescribed medication. Journal of Pharmaceutical Marketing & Management 7 (1993) 85-95
56. Doucette W.R., and Wiederholt J.B. Measurement of product meaning for prescribed medication using a Means-End Chain Model. Journal of Health Care Marketing 12 (1992) 48-54
57. Gazmararian J.A., Baker D.W., Williams M.V., et al. Health literacy among medicare enrollees in a managed care organization. Journal of the American Medical Association 281 (1999) 545-551
58. Gutman J. A Means-End Chain Model based on consumer categorization processes. Journal of Marketing 46 (1982) 60-72
59. Malhotra N.K. Information load and consumer decision making. Journal of Consumer Research 8 (1982) 419-430
60. Yoon C. Age differences in consumers' processing strategies: an investigation of moderating influences. Journal of Consumer Research 24 (1997) 329-342
61. Bettman J.R. An Information Processing Theory of Consumer Choice (1979), Addison-Wesley, Reading, Mass
62. Labor S.L., Schommer J.C., and Pathak D.S. Information overload with written prescription drug information. Drug Information Journal 29 (1995) 1317-1328
63. Lowrey T.M. The effects of syntactic complexity on advertising persuasiveness. Journal of Consumer Psychology 7 (1998) 187-206
64. Morrow D.G., Leirer V.O., Andrassy J.M., Decker Tanke E., and Stine-Morrow E.A.L. Medication instruction design: younger and older adult schemas for taking medication. Human Factors 38 (1996) 556-573
65. Petty R.E., and Cacioppo J.T. Communication and Persuasion: Central and Peripheral Routes to Attitude Change (1986), Springer-Verlag, New York
66. Cacioppo J.T., and Petty R.E. The need for cognition. Journal of Personality and Social Psychology 42 (1982) 116-131
67. Dillman D.A. Mail and Internet Surveys: The Tailored Design Method. 2nd ed. (2000), John Wiley & Sons, Inc, New York